AU Patent

AU3633295A — Retinoid compositions

Assigned to Johnson and Johnson Medical KK · Expires 1996-03-27 · 30y expired

What this patent protects

Patent listed against Jublia.

Drugs covered by this patent

Jublia (EFINACONAZOLE) · Bausch Health

Patent Metadata

Patent number: AU3633295A
Jurisdiction: AU
Classification: —
Expires: 1996-03-27
Drug substance claim: No
Drug product claim: No
Assignee: Johnson and Johnson Medical KK
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.